Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney

Cancer Discovery - Tập 6 Số 11 - Trang 1258-1266 - 2016
Rohit Mehra1,2,3, Pankaj Vats1,3,4, Marcin Cieślik3, Xuhong Cao3,5, Fengyun Su3, Sudhanshu Shukla3, Aaron M. Udager1, Rui Wang3, Jincheng Pan6, Katayoon Kasaian3, Robert J. Lonigro3, Javed Siddiqui3, Kumpati Premkumar4, Ganesh S. Palapattu7, Alon Z. Weizer2,7, Khaled S. Hafez7, Julian Wolf7, Ankur R. Sangoi8, Kiril Trpkov9, Adeboye O. Osunkoya10, Ming Zhou11, Giovanna A. Giannico12, Jesse K. McKenney13, Saravana M. Dhanasekaran1,3, Arul M. Chinnaiyan1,2,3,5,7
11Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan.
22Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan.
33Michigan Center for Translational Pathology, Ann Arbor, Michigan.
44Department of Biomedical Science, School of Basic Medical Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
55Howard Hughes Medical Institute, Ann Arbor, Michigan.
66Department of Urology, First Affiliated Hospital, Sun-Yat Sen University, Guangzhou, China.
77Department of Urology, University of Michigan Health System, Ann Arbor, Michigan.
88El Camino Hospital, Department of Pathology, Mountain View, California.
99Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
1010Departments of Pathology and Urology, Emory University School of Medicine, Atlanta, Georgia.
1111Department of Pathology, New York University School of Medicine, New York, New York.
1212Departments of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
1313Cleveland Clinic, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland, Ohio.

Tóm tắt

Abstract

Mucinous tubular and spindle cell carcinoma (MTSCC) is a relatively rare subtype of renal cell carcinoma (RCC) with distinctive morphologic and cytogenetic features. Here, we carry out whole-exome and transcriptome sequencing of a multi-institutional cohort of MTSCC (n = 22). We demonstrate the presence of either biallelic loss of Hippo pathway tumor suppressor genes (TSG) and/or evidence of alteration of Hippo pathway genes in 85% of samples. PTPN14 (31%) and NF2 (22%) were the most commonly implicated Hippo pathway genes, whereas other genes such as SAV1 and HIPK2 were also involved in a mutually exclusive fashion. Mutations in the context of recurrent chromosomal losses amounted to biallelic alterations in these TSGs. As a readout of Hippo pathway inactivation, a majority of cases (90%) exhibited increased nuclear YAP1 protein expression. Taken together, nearly all cases of MTSCC exhibit some evidence of Hippo pathway dysregulation.

Significance: MTSCC is a rare and relatively recently described subtype of RCC. Next-generation sequencing of a multi-institutional MTSCC cohort revealed recurrent chromosomal losses and somatic mutations in the Hippo signaling pathway genes leading to potential YAP1 activation. In virtually all cases of MTSCC, there was evidence of Hippo pathway dysregulation, suggesting a common mechanistic basis for this disease. Cancer Discov; 6(11); 1258–66. ©2016 AACR.

This article is highlighted in the In This Issue feature, p. 1197

Từ khóa


Tài liệu tham khảo

Cancer Genome Atlas Research Network, 2013, Comprehensive molecular characterization of clear cell renal cell carcinoma, Nature, 499, 43, 10.1038/nature12222

Linehan, 2016, Comprehensive molecular characterization of papillary renal-cell carcinoma, N Engl J Med, 135

Davis, 2014, The somatic genomic landscape of chromophobe renal cell carcinoma, Cancer Cell, 26, 319, 10.1016/j.ccr.2014.07.014

Fine, 2006, Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney, Am J Surg Pathol, 30, 1554, 10.1097/01.pas.0000213271.15221.e3

Reuter, 2014, Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference, Am J Surg Pathol, 38, e35, 10.1097/PAS.0000000000000258

Cieslik, 2015, The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing, Genome Res, 25, 1372, 10.1101/gr.189621.115

Mody, 2015, Integrative clinical sequencing in the management of refractory or relapsed cancer in youth, Jama, 314, 913, 10.1001/jama.2015.10080

Robinson, 2013, Activating ESR1 mutations in hormone-resistant metastatic breast cancer, Nat Genet, 45, 1446, 10.1038/ng.2823

Alexandrov, 2013, Signatures of mutational processes in human cancer, Nature, 500, 415, 10.1038/nature12477

Salah, 2011, Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity, Cancer Res, 71, 2010, 10.1158/0008-5472.CAN-10-3516

Schramm, 2015, Mutational dynamics between primary and relapse neuroblastomas, Nat Genet, 47, 872, 10.1038/ng.3349

Liu, 2013, PTPN14 interacts with and negatively regulates the oncogenic function of YAP, Oncogene, 32, 1266, 10.1038/onc.2012.147

Yu, 2015, Hippo pathway in organ size control, tissue homeostasis, and cancer, Cell, 163, 811, 10.1016/j.cell.2015.10.044

Harvey, 2013, The Hippo pathway and human cancer, Nat Rev Cancer, 13, 246, 10.1038/nrc3458

Halder, 2011, Hippo signaling: growth control and beyond, Development, 138, 9, 10.1242/dev.045500

Peckova, 2015, Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma, Ann Diagn Pathol, 19, 226, 10.1016/j.anndiagpath.2015.04.004

Udager, 2014, Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution, Cancer J, 20, 29, 10.1097/PPO.0000000000000017

Avruch, 2012, Protein kinases of the Hippo pathway: regulation and substrates, Semin Cell Dev Biol, 23, 770, 10.1016/j.semcdb.2012.07.002

Moya, 2014, Discovering the Hippo pathway protein-protein interactome, Cell Res, 24, 137, 10.1038/cr.2014.6

Couzens, 2013, Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions, Sci Signaling, 6, rs15, 10.1126/scisignal.2004712

Wang, 2014, Defining the protein–protein interaction network of the human hippo pathway, Mol Cell Proteomics, 13, 119, 10.1074/mcp.M113.030049

Alder, 2014, Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation, Cell Rep, 9, 261, 10.1016/j.celrep.2014.08.046

Yimlamai, 2014, Hippo pathway activity influences liver cell fate, Cell, 157, 1324, 10.1016/j.cell.2014.03.060

Kanazawa, 2011, Hepatocyte nuclear factor 4 alpha is associated with mesenchymal–epithelial transition in developing kidneys of C57BL/6 mice, J Vet Med Sci, 73, 601, 10.1292/jvms.10-0493

Kanazawa, 2010, Hepatocyte nuclear factor 4 alpha is related to survival of the condensed mesenchyme in the developing mouse kidney, Dev Dyn, 239, 1145, 10.1002/dvdy.22276

Mele, 2015, Human genomics. The human transcriptome across tissues and individuals., Science, 348, 660, 10.1126/science.aaa0355

Kanazawa, 2009, Expression of hepatocyte nuclear factor 4alpha in developing mice, Anat Histol Embryol, 38, 34, 10.1111/j.1439-0264.2008.00889.x

Suh, 2006, The expression profiles of nuclear receptors in the developing and adult kidney, Mol Endocrinol, 20, 3412, 10.1210/me.2006-0312

Saadettin, 1996, Human renal cell carcinogensis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4A and HNF1A, Cancer Lett, 101, 205, 10.1016/0304-3835(96)04136-5

Cheval, 2012, Of mice and men: divergence of gene expression patterns in kidney, PloS One, 7, e46876, 10.1371/journal.pone.0046876

Lee, 2015, Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes, J Am Soc Nephrol, 26, 2669, 10.1681/ASN.2014111067

Srigley, 2002, Phenotypic, molecular and utrastructural studies of a novel low grade renal epithelial neoplasm possibly related to the loop of Henle, Mod Pathol, 15

Bonilla, 2016, Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma, Nat Genet, 48, 398, 10.1038/ng.3525

Rakozy, 2002, Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features, Mod Pathol, 15, 1162, 10.1097/01.MP.0000031709.40712.46

Harms, 2015, The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma, Cancer Res, 75, 3720, 10.1158/0008-5472.CAN-15-0702

Mehra, 2014, Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing, Am J Pathol, 184, 584, 10.1016/j.ajpath.2013.11.023

Robinson, 2015, Integrative clinical genomics of advanced prostate cancer, Cell, 161, 1215, 10.1016/j.cell.2015.05.001

Koboldt, 2012, VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res, 22, 568, 10.1101/gr.129684.111

Li, 2009, The sequence alignment/map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352

Wang, 2010, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res, 38, e164, 10.1093/nar/gkq603

Lonigro, 2011, Detection of somatic copy number alterations in cancer using targeted exome capture sequencing, Neoplasia, 13, 1019, 10.1593/neo.111252

Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635

Dobin, 2015, Mapping RNA-seq reads with STAR, Current Protocols Bioinformat, 51, 11 4 1, 10.1002/0471250953.bi1114s51

Liao, 2013, The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote, Nucleic Acids Res, 41, e108, 10.1093/nar/gkt214

Ritchie, 2015, limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res, 43, e47, 10.1093/nar/gkv007

Smyth, 2004, Linear models and empirical Bayes methods for assessing differential expression in microarray experiments, Stat Appl Genet Mol Biol, 3, Article3, 10.2202/1544-6115.1027

Law, 2014, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol, 15, R29, 10.1186/gb-2014-15-2-r29

Chen, 2016, Multilevel genomics-based taxonomy of renal cell carcinoma, Cell Rep, 14, 2476, 10.1016/j.celrep.2016.02.024

Hoyer, 2004, Non-negative matrix factorization with sparseness constraints, J Mach Learning Res, 5, 1457

Newton, 2007, Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis, Ann Appl Stat, 85